Loading live market data…

AbCellera Biologics Inc.

NASDAQ:ABCL

$6.74 USD

$0 (0.0%)

Volume
3.72M
Average Volume
8.14M
Market Capitalization
$2.06B
P/E Ratio
-14.04
Dividend Yield
0.00%
Price Target
$7.50
Year High
$8.44
Year Low
$2.75
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$14.05

ABCL Estimated and Actual Revenue by Quarter

ABCL Estimated and Actual EPS by Quarter

ABCL Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 2 -4.37M -2.47M -3.21M -4.64M -2.62M -3.41M
2027-09-30 2 -4.16M -2.35M -3.06M -4.42M -2.5M -3.25M
2027-06-30 2 -4.06M -2.3M -2.99M -4.31M -2.44M -3.17M
2027-03-31 2 -3.86M -2.18M -2.84M -4.1M -2.32M -3.02M
2026-12-31 2 -4.05M -2.29M -2.98M -4.3M -2.43M -3.17M
2026-09-30 5 -3.93M -2.22M -2.79M -4.17M -2.36M -2.96M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 2 -91.15M -43.43M -62.13M 8.42M 14.89M 10.96M
2027-09-30 2 -88.93M -42.38M -60.61M 8.01M 14.17M 10.43M
2027-06-30 2 -86.7M -41.32M -59.1M 7.83M 13.84M 10.18M
2027-03-31 2 -84.48M -40.26M -57.58M 7.45M 13.17M 9.69M
2026-12-31 2 -72.41M -34.51M -49.36M 7.81M 13.81M 10.16M
2026-09-30 5 -44.16M -32.69M -38.43M 7.57M 13.39M 9.5M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 2 6.76M 11.96M 8.8M 1 -0.30075 -0.14331 -0.205
2027-09-30 2 6.43M 11.38M 8.37M 1 -0.29341 -0.13982 -0.2
2027-06-30 2 6.28M 11.11M 8.17M 1 -0.28608 -0.13632 -0.195
2027-03-31 2 5.98M 10.57M 7.78M 1 -0.27874 -0.13283 -0.19
2026-12-31 2 6.27M 11.08M 8.15M 1 -0.23893 -0.11385 -0.16286
2026-09-30 5 6.08M 10.75M 7.62M 3 -0.14572 -0.10786 -0.12678999999999999